Landcent Europe

Established in 2011, Landcent accelerates the fight against diseases of poverty, starting with malaria. We develop and deliver affordable, safe to use products and solutions that enable under served communities to prosper. Landcent is backed by the Gates Foundation and is a WHO GCDPP member. Invest with us, to wipe malaria off the map

Research & development,vector control,malaria,impact investment,social investing,public health,healthcare investment,africa investment,malaria elimination and eradication,social responsibility,social entrepreneurship,social enterprise,social impact investment company,impact investing company,esg investing company,healthful living,and disease prevention

Landcent europe operates in the Pharmaceutical manufacturing industry.

Landcent europe's revenue is 11m - 100m

Landcent europe has 11 - 50 employees.